|
[1]
|
Advancements in nanomedicines for the detection and treatment of diabetic kidney disease
Biomaterials and Biosystems,
2022
DOI:10.1016/j.bbiosy.2022.100047
|
|
|
|
|
[2]
|
Emerging nanobiotechnology-encoded relaxation tuning establishes new MRI modes to localize, monitor and predict diseases
Journal of Materials Chemistry B,
2022
DOI:10.1039/D2TB00600F
|
|
|
|
|
[3]
|
Advances in Imaging
2022
DOI:10.1007/978-981-16-9535-3_20
|
|
|
|
|
[4]
|
Biomineralized iron oxide–polydopamine hybrid nanodots for contrast-enhanced T1-weighted magnetic resonance imaging and photothermal tumor ablation
Journal of Materials Chemistry B,
2021
DOI:10.1039/D1TB00032B
|
|
|
|
|
[5]
|
Iron Oxide Nanoparticles as
T
1
Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives
Advanced Materials,
2020
DOI:10.1002/adma.201906539
|
|
|
|
|
[6]
|
A nucleic acid-specific fluorescent probe for nucleolus imaging in living cells
Talanta,
2019
DOI:10.1016/j.talanta.2018.09.022
|
|
|
|
|
[7]
|
Accomplishments and challenges in stem cell imaging in vivo
Drug Discovery Today,
2018
DOI:10.1016/j.drudis.2018.10.007
|
|
|
|
|
[8]
|
Magnetic iron oxide nanoparticles as T1 contrast agents for magnetic resonance imaging
Journal of Materials Chemistry C,
2018
DOI:10.1039/C7TC05854C
|
|
|
|
|
[9]
|
Current Perspective on In Vivo Molecular Imaging of Immune Cells
Molecules,
2017
DOI:10.3390/molecules22060881
|
|
|
|
|
[10]
|
Ultrasmall graphene oxide based T 1 MRI contrast agent for in vitro and in vivo labeling of human mesenchymal stem cells
Nanomedicine: Nanotechnology, Biology and Medicine,
2017
DOI:10.1016/j.nano.2017.03.019
|
|
|
|
|
[11]
|
T1-Enhanced MRI-visible nanoclusters for imaging-guided drug delivery
Nanoscale,
2017
DOI:10.1039/C7NR04181K
|
|
|
|
|
[12]
|
Shape-dependent cellular behaviors and relaxivity of iron oxide-based T1MRI contrast agents
Nanoscale,
2016
DOI:10.1039/C6NR06158C
|
|
|
|